Chi B. Vu
Boston University · 54 works · 3,079 citations · h-index 21
Top works
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
- Quantitative Structure−Activity Relationships among Macrolide Antibacterial Agents: In Vitro and in Vivo Potency against Pasteurella multocida
- Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with in vivo antiresorptive activity
- Formation of vicinal tricarbonyl compounds by selective oxidation of ylides using potassium peroxymonosulfate
- Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70
- The chemistry of vicinal tricarbonyls
- Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists
- Discovery of Imidazo[1,2- b ]thiazole Derivatives as Novel SIRT1 Activators
- The chemistry of vicinal tricarbonyls. New routes to indolizidines
- Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators
- Novel Bicyclic Piperazine Derivatives of Triazolotriazine and Triazolopyrimidines as Highly Potent and Selective Adenosine A2AReceptor Antagonists
- Structure-activity relationships of a novel class of Src SH2 inhibitors
- The chemistry of vicinal tricarbonyls. Formation of carbazole derivatives.
- Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles
- Vicinal tricarbonyls in synthesis. New routes to indolizidines.
- Piperazine Derivatives of [1,2,4]Triazolo[1,5-a][1,3,5]triazine as Potent and Selective Adenosine A2aReceptor Antagonists
- Intramolecular alkylation of 3-hydroxypyrrole-2-carboxylates. Formation of , , and ring systems related to pyrrolidine alkaloids
- Novel Diamino Derivatives of [1,2,4]Triazolo[1,5-a][1,3,5]triazine as Potent and Selective Adenosine A2aReceptor Antagonists
- Bone-Targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents
- Cyclic homopentapeptides 3. Synthetic modifications to the capreomycins and tuberactinomycins: Compounds with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci